<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=395457600911184&amp;ev=PageView&amp;noscript=1">

Legal investigations into transvaginal mesh defects are ongoing

At Bart Durham Injury Law, we are constantly monitoring product safety issues affecting the people of Nashville, and one of the matters we are currently investigating involves defective transvaginal mesh. At the moment, we are looking into claims against five different companies that manufactured this medical device.

Transvaginal mesh is used to treat medical conditions involving weakened vaginal tissue, such as Stress Urinary Incontinence and Pelvic Organ Prolapse. When implanted, these meshes reinforce vaginal walls. 

According to a safety communication by the FDA, the use of these medical devices resulted in over 3,800 reports of consumer injury from 2005 to 2010. Complications resulting from the use of transvaginal mesh can include:

  • Organ perforation
  • Infection
  • Incontinence
  • Vaginal scarring/shrinkage
  • Painful intercourse
  • Neuro-muscular problems

The FDA initially brought this issue to the public’s attention in October 2008, stating that the problem was serious but rare. In a 2011 update the agency changed its stance, warning consumers that it was not rare for complications to arise after the surgical implantation of transvaginal mesh for the treatment of POP.

In addition, the FDA noted that its investigations into the matter revealed that it is unclear whether transvaginal mesh is an effective POP treatment. The agency also stated that mesh implantations could put patients at greater risk than non-mesh treatments.

Those who have been injured as a result of transvaginal mesh treatments may be able to receive compensation for their financial losses, as well as for their pain and suffering. If you would like more information on the legal options available to those who have been injured due to defective transvaginal mesh, please see our page on the topic. 

Recent Posts

    Archives

    View All